11 reports

  • NOV 14, 2017: HOSPITAL AWARDED $7.9M GRANT FOR PEDIATRIC ASTHMA CARE
  • SEP 28, 2017: NEURO-IMMUNE CROSSTALK IN ALLERGIC ASTHMA

Summary National Heart Lung and Blood Institute (NHLBI), a subsidiary of National Institutes of Health is a medical research institute that provides treatment for heart, lung, and blood diseases.The institute conducts research studies with patients who have diseases of heart and blood vessels, lungs, blood cells and bone...

  • Asthma
  • Cardiovascular Disease
  • Healthcare
  • Respiratory Disease
  • United States
  • asthma therapy.
  • Asthma - Dormant Projects

Asthma - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Asthma - Pipeline Review, H1 2018, provides an overview of the Asthma (Respiratory) pipeline landscape. Asthma is a chronic disease involving the airways in the lungs....

  • Asthma
  • Research And Development
  • United States
  • Company
  • AstraZeneca PLC
  • Other Significant Developments Feb 28, 2017: Respiri's Text and App Messaging for Better Asthma Care
  • Deal Sub Type

Summary Respiri Ltd (Respiri), formerly iSonea Ltd, is a medical technology company that develops non-invasive medical devices and mobile health applications to improve the management of chronic respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). The company’s proprietary applications,...

  • Asthma
  • Australia
  • United States
  • World
  • Company
  • 01/10/2018: ASTRAZENECA RECEIVES EU APPROVAL OF FASENRA FOR SEVERE EOSINOPHILIC ASTHMA
  • 11/14/2017: FASENRA (BENRALIZUMAB) RECEIVES US FDA APPROVAL FOR SEVERE EOSINOPHILIC ASTHMA

Summary Kyowa Hakko Kirin Co Ltd (Kyowa Hakko), a subsidiary of Kirin Holdings Company Limited, is a research and development (R&D) based biotechnology company.It focuses on the discovery, development, production and commercialization of pharmaceuticals and biotechnology products. The company offers drugs in the...

  • Asthma
  • Japan
  • United States
  • Company
  • Kyowa Hakko Kirin Co., Ltd.
  • who participated in a previous dupilumab asthma clinical study. The trial is registered with the EU Clinical Trials Register.
  • RG-6149 - DRUG PROFILE

Nasal Polyps - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Nasal Polyps - Pipeline Review, H1 2018, provides an overview of the Nasal Polyps (Ear Nose Throat Disorders) pipeline landscape. Nasal polyps (Nasal polyposis)...

  • Asthma
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • Regeneron Pharmaceuticals, Inc.
  • Jan 24, 2017: FDA approves IND to support Vectura's wholly-owned programme VR647 in paediatric asthma
  • Deal Type

Summary Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform.It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, pulmonary...

  • Asthma
  • United Kingdom
  • United States
  • Company Financials
  • Vectura Group plc
  • Product Description
  • Product Description

Dr Stephens is regarded as one of Australia' s foremost experts in the field of ovarian cancer research.

  • Asthma
  • Australia
  • Company
  • M&A
  • Invion Limited
  • SKP-2075 - PRODUCT DESCRIPTION
  • RPL554 - DRY POWDER INHALER - PRODUCT DESCRIPTION

Inhalers - Medical Devices Pipeline Assessment, 2018 Summary GlobalData’s Medical Devices sector report, “Inhalers - Medical Devices Pipeline Assessment, 2018" provides an overview of Inhalers currently in pipeline stage. The report provides comprehensive information on the pipeline products...

  • Asthma
  • Respiratory Disease
  • United States
  • Company Financials
  • Orion Corporation
  • ASTRAZENECA ENTERS INTO LICENSING AGREEMENT WITH SYNAIRGEN FOR SNG001
  • PARTNERSHIPS

It targets interferon alpha receptor ## and ##.

  • Asthma
  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Synairgen plc
  • PHARMAXIS EXPANDS AGREEMENT WITH SYNAIRGEN
  • PHARMAXIS ENTERS INTO DISTRIBUTION AGREEMENT WITH CHIESI FARMACEUTICI

The current products for IPF have generated global revenues in excess of $## billion in 2016.

  • Asthma
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Pharmaxis Ltd
  • ASTHMA THERAPY.
  • PERIOSTIN IN ASTHMA.

Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2018, provides an overview of the Idiopathic Pulmonary Fibrosis (Respiratory) pipeline landscape. Idiopathic...

  • Asthma
  • Research And Development
  • United States
  • Product Initiative
  • ProMetic Life Sciences Inc.